Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12

NCT: NCT05454189 · ACTIVE_NOT_RECRUITING

NCT IDNCT05454189
StatusACTIVE_NOT_RECRUITING
Start Date2022-10-11
Completion2026-12-31

Brief Summary

Implanted port devices (IPD) play an essential role in the safe administration of cancer treatments by providing a device to safely administer caustic chemotherapy agents. The current recommended frequency of flushing the IPD per manufacturers guidelines is every 4-6 weeks. The purpose of this study is to find out if extending IPD flushes to every 12 weeks is safe and if it is just as effective as every 4 week flushing.

Frequently Asked Questions

What is Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12?

Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12 is a clinical trial registered under NCT05454189. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05454189?

The current status of NCT05454189 (Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12) is: ACTIVE_NOT_RECRUITING.

When did Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12 start?

Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12 started on 2022-10-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑